Voyager Therapeutics Inc

VYGR

Company Profile

  • Business description

    Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

  • Contact

    75 Hayden Avenue
    LexingtonMA02421
    USA

    T: +1 857 259-5340

    E: [email protected]

    https://www.voyagertherapeutics.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    172

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,424.8059.100.71%
CAC 407,593.8738.000.50%
DAX 4022,496.9871.150.32%
Dow JONES (US)40,752.9683.600.21%
FTSE 1008,496.801.950.02%
HKSE22,411.22291.811.32%
NASDAQ17,710.74264.401.52%
Nikkei 22536,705.53253.230.69%
NZX 50 Index12,317.68169.081.39%
S&P 5005,604.1435.080.63%
S&P/ASX 2008,204.1058.500.72%
SSE Composite Index3,279.037.62-0.23%

Market Movers